Corcept Therapeutics
CORT
#1631
Rank
ยฃ9.89 B
Marketcap
ยฃ91.58
Share price
2.24%
Change (1 day)
65.13%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of June 2026 : ยฃ0.23 Billion

According to Corcept Therapeutics 's latest financial reports the company has ยฃ0.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ0.27 B-9.54%
2024-12-31ยฃ0.30 B5.69%
2023-12-31ยฃ0.28 B-19%
2022-12-31ยฃ0.35 B115.46%
2021-12-31ยฃ0.16 B-48.78%
2020-12-31ยฃ0.32 B53.63%
2019-12-31ยฃ0.21 B29.2%
2018-12-31ยฃ0.16 B148.06%
2017-12-31ยฃ65.66 M57.21%
2016-12-31ยฃ41.76 M53.07%
2015-12-31ยฃ27.28 M75.19%
2014-12-31ยฃ15.57 M-53.19%
2013-12-31ยฃ33.26 M-42.2%
2012-12-31ยฃ57.55 M125.72%
2011-12-31ยฃ25.5 M60.16%
2010-12-31ยฃ15.92 M7.95%
2009-12-31ยฃ14.74 M18.06%
2008-12-31ยฃ12.49 M42.91%
2007-12-31ยฃ8.74 M81.07%
2006-12-31ยฃ4.82 M-71.37%
2005-12-31ยฃ16.86 M-13.44%
2004-12-31ยฃ19.48 M201.01%
2003-12-31ยฃ6.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
ยฃ15.68 B 6,635.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.81 B 2,395.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ8.83 B 3,695.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ6.76 B 2,803.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.39 B 2,217.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.36 B 3,490.89%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ83.97 M-63.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.11 B-49.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.66 B 183.59%๐Ÿ‡บ๐Ÿ‡ธ USA